Edouard Ollier (E Ollier)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 10

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Methicillin Resistant Staphylococcus Aureus

Top Venues

British journal of clinical pharmacology

Fundamental & clinical pharmacology

Statistics in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Lanoiselée, Jérémy Mourer, Marie Jungling, Serge Molliex, Lise Thellier, Julien Tabareau, Emmanuelle Jeanpierre, Emmanuel Robin, Sophie Susen, Benoit Tavernier, André Vincentelli, Edouard Ollier, Mouhamed Djahoum Moussa
Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis. Pharmaceutics 16 (6) (2024)
Julien Lanoiselée, Jérémy Mourer, Marie Jungling, Serge Molliex, Lise Thellier, Julien Tabareau, Emmanuelle Jeanpierre, Emmanuel Robin, Sophie Susen, Benoit Tavernier, André Vincentelli, Edouard Ollier, Mouhamed Djahoum Moussa
Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis. Pharmaceutics 16 (6) (2024)
Céline Chapelle, Gwénaël Le Teuff, Paul Jacques Zufferey, Silvy Laporte, Edouard Ollier
A framework to characterise the reproducibility of meta-analysis results with its application to direct oral anticoagulants in the acute treatment of venous thromboembolism. Research synthesis methods (2023)
Audrick Gibert, Julien Lanoiselée, Luc Janisset, Gilles Pernod, Edouard Ollier, Xavier Delavenne
Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high-bleeding risk procedure. Fundamental & clinical pharmacology 36 (5) (2022)
Delphine Douillet, C Chapelle, Edouard Ollier, P Mismetti, P-M Roy, Silvy Laporte
Prevention of venous thromboembolic events in patients with lower leg immobilization after trauma: Systematic review and network meta-analysis with meta-epsidemiological approach. PLoS medicine 19 (7) (2022)
Edouard Ollier, Pierre Blanchard, Gwénaël Le Teuff, Stefan Michiels
Penalized Poisson model for network meta-analysis of individual patient time-to-event data. Statistics in medicine (2021)
Guillaume Claisse, Paul J Zufferey, Jane C Trone, Nicolas Maillard, Xavier Delavenne, Silvy Laporte, Edouard Ollier
Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach. British journal of clinical pharmacology 85 (6) (2019)
Xavier Delavenne, Yesim Dargaud, Edouard Ollier, Claude Négrier
Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A. British journal of clinical pharmacology 85 (4) (2019)
Paul J Zufferey, Edouard Ollier, Xavier Delavenne, S Laporte, P Mismetti, S B Duffull
Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time-to-event analysis. British journal of clinical pharmacology 84 (10) (2018)
Julien Lanoiselée, Paul J Zufferey, Edouard Ollier, Sophie Hodin, Xavier Delavenne, null null
Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study. British journal of clinical pharmacology 84 (2) (2017)
Edouard Ollier, Fabrice Heritier, Caroline Bonnet, Sophie Hodin, Brigitte Beauchesne, Serge Molliex, Xavier Delavenne
Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection. British journal of clinical pharmacology 80 (1) (2015)